Search results for "slas europe 2018"

In a guest editorial from H.E.L Group, explore how pressurized bioreactors and synthetic biology can mitigate the dangerous effects of climate change

Scientists at the National Center for Research on Human Genomics are at the forefront of groundbreaking research to develop new drugs for major diseases

Rapid human ID STR assays for forensic casework, databasing and relationship testing.

Innovative new sample tubes enable full tracebility, minimize contamination and improve storage effiiency

Insights from the Compound Combination Special Interest Group Co-Chair, Dr Oliver Leven

Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people

New transfection reagent is an efficient, stable, and safe delivery system leading to 100% mRNA encapsulation for comparable LNP delivery

The Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research

Expanding CRISPR screening technology to ex vivo primary T cells through a combined lentiviral and electroporation approach

Acquisition expands portfolio of Lab Products & Services division, incorporating unique technology for cell analysis in biopharma applications

Certified quality of analytical services for developers of biologics and biosimilars

The platform combines data from multiple sources including genomics, medical devices and bio-markers, to deliver evidence-based insights

Merck's immuno-oncology cell lines are innovative research tools for biologics discovery and clinical development. These are the perfect cell-based assay tools you need for the entire drug discovery and clinical development process. Whether you need screening tools for CAR/TCR therapies and mAB development, target cells for efficacy testing, or potency assays for clinical development, Merck provides functional biologically-re…

The new state-of-the-art complex further strengthens its commitment to the greater Loveland, Colorado community

Research confirms the unmet need for an effective alternative to unenhanced MRI and a safe alternative to GBCAs